Psychosocial Predictors of Non-Adherence and Treatment Failure in a Large Scale Multi-National Trial of Antiretroviral Therapy for HIV: Data from the ACTG A5175/PEARLS Trial
Steven A. Safren(University of Miami), Aadia Rana(University of Alabama at Birmingham), David D. Celentano(Johns Hopkins University), Thomas Campbell(University of Colorado Anschutz Medical Campus), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Wadzanai Samaneka(University of Zimbabwe), James Hakim(University of Zimbabwe), Jocelyn E. Remmert(Massachusetts General Hospital), Umesh Lalloo(Wentworth Hospital), Ann Walawander(Frontier Science & Technology Research Foundation, Inc.), Matthew J. Mimiaga(UCLA Health), Laura Smeaton(Cancer Research And Biostatistics), Mulinda Nyirenda(University of Malawi), Virginia Kayoyo, Katie B. Biello(Harvard University), Anjali Joglekar(National AIDS Research Institute), Javier R. Lama(Asociación Civil Impacta Salud y Educación), Nagalingeswaran Kumarasamy(YR Gaitonde Centre for AIDS Research and Education)
Cited by 55
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557